Wilbanks Smith & Thomas Asset Management’s Zimmer Biomet ZBH Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-25,420	Closed	-$2.56M	–	424
2018 Q4	$2.56M	Sell	25,420 -802	-3%	-$90.2K	0.18%	93
2018 Q3	$3.35M	Buy	26,222 +814	+3%	+$96.8K	0.2%	94
2018 Q2	$2.75M	Buy	25,408 +999	+4%	+$109K	0.22%	84
2018 Q1	$2.58M	Buy	24,409 +907	+4%	+$105K	0.21%	85
2017 Q4	$2.75M	Buy	23,502 +567	+2%	+$64.1K	0.22%	82
2017 Q3	$2.61M	Buy	22,935 +320	+1%	+$36.9K	0.22%	82
2017 Q2	$2.82M	Buy	22,615 +674	+3%	+$79.9K	0.25%	77
2017 Q1	$2.6M	Sell	21,941 -113	-0.5%	-$12.8K	0.22%	79
2016 Q4	$2.21M	Buy	22,054 +1,772	+9%	+$190K	0.2%	84
2016 Q3	$2.56M	Sell	20,282 -870	-4%	-$107K	0.24%	73
2016 Q2	$2.47M	Sell	21,152 -500	-2%	-$56.6K	0.26%	72
2016 Q1	$2.24M	Buy	21,652 +1,839	+9%	+$178K	0.27%	76
2015 Q4	$1.97M	Buy	+19,813	New	+$1.94M	0.19%	82

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's ZBH Position: Q1 2019 in Review

Wilbanks Smith & Thomas Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 25,420 shares — an estimated $2.56M sold.

Wilbanks Smith & Thomas Asset Management first reported a position in ZBH in Q4 2015 and held it in 13 quarters. The position peaked at $3.35M in Q3 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

Wilbanks Smith & Thomas Asset Management reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
Wilbanks Smith & Thomas Asset Management sold 25,420 Zimmer Biomet shares in Q1 2019, an estimated $2.56M.
Wilbanks Smith & Thomas Asset Management first reported a position in Zimmer Biomet in Q4 2015 and held it in 13 quarters.
Wilbanks Smith & Thomas Asset Management's Zimmer Biomet position peaked at $3.35M in Q3 2018.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2019, filed 13 May 2019.